Hcy、Cys C、hs-CRP浓度在评估缺血性脑卒中患者功能预后中的价值

周婷, 花嵘, 陈令东, 等. Hcy、Cys C、hs-CRP浓度在评估缺血性脑卒中患者功能预后中的价值[J]. 临床急诊杂志, 2021, 22(5): 347-351. doi: 10.13201/j.issn.1009-5918.2021.05.012
引用本文: 周婷, 花嵘, 陈令东, 等. Hcy、Cys C、hs-CRP浓度在评估缺血性脑卒中患者功能预后中的价值[J]. 临床急诊杂志, 2021, 22(5): 347-351. doi: 10.13201/j.issn.1009-5918.2021.05.012
The value of Hcy, Cys C and hs-CRP serum concentrations in evaluating the functional prognosis of patients with ischemic stroke[J]. J Clin Emerg, 2021, 22(5): 347-351. doi: 10.13201/j.issn.1009-5918.2021.05.012
Citation: The value of Hcy, Cys C and hs-CRP serum concentrations in evaluating the functional prognosis of patients with ischemic stroke[J]. J Clin Emerg, 2021, 22(5): 347-351. doi: 10.13201/j.issn.1009-5918.2021.05.012

Hcy、Cys C、hs-CRP浓度在评估缺血性脑卒中患者功能预后中的价值

  • 基金项目:

    徐州市国家临床重点专科培育项目(No:2018ZK004)

详细信息
    通讯作者: 许铁,E-mail:xutie889@163.com
  • 中图分类号: R743.3

The value of Hcy, Cys C and hs-CRP serum concentrations in evaluating the functional prognosis of patients with ischemic stroke

More Information
  • 加载中
  • [1]

    Roger VL,Go AS,Lloyd-Jones DM,et al.Heart disease and stroke statistics——2011 update:a report from the American Heart Association[J].Circulation,2011,123(4):e18-e209.

    [2]

    《中国心血管病报告2017》概要[J].中国循环杂志,2018,33(1):1-8.

    [3]

    Wang P,Liu J,Lv X,et al.A naphthalimide-based glyoxal hydrazone for selective fluorescence turn-on sensing of Cys and Hcy[J].Org Lett,2012,14(2):520-523.

    [4]

    Banecka-Majkutewicz Z,Sawula W,Kadzinski L,et al.Homocysteine,heat shock proteins,genistein and vitamins in ischemic stroke——pathogenic and therapeutic implications[J].Acta Biochim Pol,2012,59(4):495-499.

    [5]

    Nenseter MS,Ueland T,Retterstol K,et al.Dysregulated RANK ligand/RANK axis in hyperhomocysteinemic subjects:effect of treatment with B-vitamins[J].Stroke,2009,40(1):241-247.

    [6]

    李庆,方凯,张成伟,龙琴,李翠翠.肌红蛋白和胱抑素C联合改良HEART评分法对急诊胸痛早期危险分层的临床价值分析[J].临床急诊杂志,2020,21(5):402-408.

    [7]

    Huang GX,Ji XM,Ding YC,et al.Association between serum cystatin C levels and the severity or potential risk factors of acute ischemic stroke[J].Neurol Res,2016,38(6):518-523.

    [8]

    中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682.

    [9]

    Thrift AG,Thayabaranathan T,Howard G,et al.Global stroke statistics[J].Int J Stroke,2017,12(1):13-32.

    [10]

    McNaughton H,DeJong G,Smout RJ,et al.A comparison of stroke rehabilitation practice and outcomes between New Zealand and United States facilities[J].Arch Phys Med Rehabil,2005,86(12 Suppl 2):S115-S120.

    [11]

    Emerging Risk Factors Collaboration,Kaptoge S,Di Angelantonio E,et al.C-reactive protein concentration and risk of coronary heart disease,stroke,and mortality:an individual participant meta-analysis[J].Lancet,2010,375(9709):132-140.

    [12]

    Meschia JF,Bushnell C,Boden-Albala B,et al.Guidelines for the primary prevention of stroke:a statement for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2014,45(12):3754-3832.

    [13]

    Li T,Chen Y,Li J,et al.Serum Homocysteine Concentration Is Significantly Associated with Inflammatory/Immune Factors[J].PLoS One,2015,10(9):e0138099.

    [14]

    Fava C,Montagnana M.Atherosclerosis is an inflammatory disease which lacks a common anti-inflammatory therapy:How human genetics can help to this issue.a narrative reveiw[J].Front Pharmacol,2018,9(1):55.

    [15]

    姜柳米,王进平,张敏,等.急性缺血性脑卒中患者血清NSE、hs-CRP水平与脑梗死体积、NIHSS评分的关系及临床指导意义[J].临床急诊杂志,2019,20(2):132-135.

    [16]

    Pang X,Liu J,Zhao J,et al.Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-κB signal pathway in rat vascular smooth muscle cells[J].Atherosclerosis,2014,236(1):73-81.

    [17]

    Nabipour I,Vahdat K,Jafari SM,et al.Correlation of hyperhomocysteinaemia and Chlamydia pneumoniae IgG seropositivity with coronary artery disease in a general population[J].Heart Lung Circ,2007,16(6):416-422.

    [18]

    Harris S,Rasyid A,Kurniawan M,et al.Association of High Blood Homocysteine and Risk of Increased Severity of Ischemic Stroke Events[J].Int J Angiol,2019,28(1):34-38.

    [19]

    Shlipak MG,Matsushita K,Arnlov J,et al.Cystatin C versus creatinine in determining risk based on kidney function[J].N Engl J Med,2013,369(10):932-943.

    [20]

    Inker LA,Schmid CH,Tighiouart H,et al.Estimating glomerular filtration rate from serum creatinine and cystatin C[J].N Engl J Med,2012,367(1):20-29.

    [21]

    Wang Y,Li W,Yang J,et al.Association Between Cystatin C and the Risk of Ischemic Stroke:a Systematic Review and meta-analysis[J].J Mol Neurosci,2019,69(3):444-449.

    [22]

    冯涛.血清胱抑素C和同型半胱氨酸与急性脑梗死相关性分析[J].实用医药杂志,2019,36(4):323-325.

    [23]

    乔莉霞,陈昊阳,鞠应秋.Hcy、Cys C、NT-proBNP、D-二聚体在急性缺血性脑卒中患者血浆中变化意义研究[J].中国急救复苏与灾害医学杂志,2020,15(6):683-686.

  • 加载中
计量
  • 文章访问数:  195
  • PDF下载数:  85
  • 施引文献:  0
出版历程
收稿日期:  2020-12-14

目录